Change of Fagotti score is associated with outcome after neoadjuvant chemotherapy for ovarian cancer.
Flurina Anna-Carina Maria SanerGiovanni RuggeriFranziska SiegenthalerJulian WampflerSara ImbodenMichael D MuellerPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Fagotti scores and ΔFagotti scores are associated with complete cytoreduction at interval debulking surgery and longer overall survival in women treated with neoadjuvant chemotherapy for ovarian cancer. These markers are valuable for individualized patient treatment planning and should always be performed after neoadjuvant therapy.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- lymph node
- rectal cancer
- sentinel lymph node
- squamous cell carcinoma
- minimally invasive
- radiation therapy
- coronary artery bypass
- polycystic ovary syndrome
- case report
- surgical site infection
- pregnancy outcomes
- adipose tissue
- pregnant women
- mesenchymal stem cells
- percutaneous coronary intervention
- cell therapy
- cervical cancer screening
- breast cancer risk